Aqua Bio Technology, a Norwegian marine biotech firm developing, producing and selling patented marine based ingredients and technologies to the international cosmetic and skin care industry, announced it has entered into a sales agreement with a highly-regarded Asian manufacturer of skin care products.
As a part of the agreement, ABT will supply its bioactive ingredient Zonase X to be the key ingredient in a new product line the manufacturer will launch in January 2011. The new line will consist of five products, developed in collaboration with ABT. The new skin care line will initially be introduced in the Asian markets through the manufacturer’s existing distribution channels. In addition, the manufacturer is also in discussion with distributors in Australia and selected European countries regarding launches in those markets. Due to competitive reasons, the manufacturer has requested that it is not named until the products are launched. The reason is that the manufacturer considers Zonase Xa novel and highly innovative technology.
